+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Lysis of fresh murine mammary tumor cells by syngeneic natural killer cells and lymphokine-activated killer cells



Lysis of fresh murine mammary tumor cells by syngeneic natural killer cells and lymphokine-activated killer cells



Cancer Immunology ImmunoTherapy 25(3): 161-168



We have compared the ability of natural killer (NK) cells from two substrains of C3H mice that differ with respect to their susceptibility to the development of mammary adenocarcinomas to lyse fresh syngeneic mammary tumor cells. Single cell suspensions of mammary tumors from retired breeder females were used as targets in 22-h 51Cr-release cytotoxicity assays with syngeneic NK cells. Tumor cell suspensions were prepared by enzymatic digestion of finely minced tissue followed by centrifugation through a discontinuous Percoll gradient. Effector cells were prepared by passing spleen cells over nylon wool followed by centrifugation through Percoll fraction 7. Syngeneic NK cells had significant levels of lysis against 5/8 tumors studied. NK cells from low risk animals (C3Heb/FeJ) consistently demonstrated greater cytotoxicity against tumor cell preparations than did effectors from the high tumor substrain (C3H/OuJ). Study of cytocentrifuge preparations stained with Wright-Giemsa revealed that the two substrains were identical with respect to the number of azurophilic granules present in the cytoplasm of their NK cells. We have also shown that lymphokine-activated killer (LAK) cells can be generated from splenocytes in C3H mice. While LAK cells from both substrains were capable of lysing fresh syngeneic mammary tumor cells in vitro, LAK cells from the animals at high risk for the formation of mammary adenocarcinomas had greater cytotoxicity against tumor cell suspensions than LAK cells from the low tumor substrain.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 040615786

Download citation: RISBibTeXText

PMID: 3499983

DOI: 10.1007/bf00199142


Related references

Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2. Cancer Research 44(5): 1946-1953, 1984

Lysis of fresh murine mammary tumor cells by syngeneic natural killer cells. Federation Proceedings 46(3): 479, 1987

Mechanism of interferon gamma-induced protection of human gliosarcoma cells from lymphokine-activated killer lysis: division of lymphokine-activated killer cells into natural killer- and T-like cells. Neurosurgery 31(3): 534-540, 1992

Lysis of fresh natural killer-resistant tumor cells by lectin-activated syngeneic and allogeneic murine splenocytes. Cancer Research 43(12 Pt 1): 5729-5734, 1983

Human oncogene-transfected tumor cells display differential susceptibility to lysis by lymphokine-activated killer cells (LAK) and natural killer cells. Journal of Immunology 137(8): 2716-2720, 1986

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. Journal of Experimental Medicine 155(6): 1823-1841, 1982

Lymphokine-activated killer cell phenomenon. Lysis of natural killer- resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. Journal of Experimental Medicine 155(6): 1823-1841, 1982

Lymphokine activated killer cell phenomenon 4. lysis by lymphokine activated killer cell clones of fresh human tumor cells from autologous and multiple allogeneic tumors. Journal of the National Cancer Institute 75(1): 67-76, 1985

Spontaneous alloreactivity of natural killer nk and lymphokine activated killer lak cells from athymic rats against normal hemic cells nk cells stimulate syngeneic but inhibit allogeneic hemopoiesis. Immunology 74(1): 86-93, 1991

Induction of murine lymphokine-activated killer-like cells by Corynebacterium parvum (C. parvum) in vitro: lysis of tumor cells and macrophages by C. parvum-induced killer cells. Anticancer Research 12(2): 451-456, 1992

Lysis of fresh autologous tumor cells by lymphokine activated killer cells in various human malignant tumors. Nihon University Journal of Medicine 28(4): 311-322, 1986

Lymphokine-activated killer cells in rats: generation of natural killer cells and lymphokine-activated killer cells from bone marrow progenitor cells. Cellular Immunology 118(2): 448-457, 1989

Lysis of human malignant mesothelioma cells by natural killer (NK) and lymphokine-activated killer (LAK) cells. American Review of Respiratory Disease 139(6): 1369-1374, 1989

Interferon-gamma reduces the sensitivity of cultured and fresh human tumor cells to lysis by lymphokine-activated killer cells. Natural Immunity and Cell Growth Regulation 7(2): 65-76, 1988

Lysis of human solid tumor cells by lymphokine-activated natural killer cells. Journal of Immunology 136(10): 3910-3915, 1986